Ariana offers comprehensive and FDA-tested clinical and biomarker data analysis services that guarantee you get the most out of your data
We deliver actionable information that improves disease diagnosis management, advances clinical development, and minimizes risk.
Using our KEM® (Knowledge, Extraction, Management) technology, Ariana
- – improves the process of identification and validation of biomarker signatures
- – increases the power of multi-parametric diagnostic tools
- – identifies best patient responder sub-groups and populations at risk of AEs, and improves clinical trial success rates.
Our technology uncovers hidden signals and complex relationships that conventional statistical analyses miss. It’s a unique approach that is both complementary to and supported by statistical analyses, guaranteeing robust, reproducible results. We can easily analyze complex combinations of data including clinical, imaging, metabolic, biochemical and NGS/omics.